Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11939380 Combination therapies targeting PD-1, TIM-3, and LAG-3

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
April 5, 2018
0
Date of Patent
March 26, 2024
0
Patent Application Number
16500918
0
Patent Citations
‌
US Patent 10550181 Anti-TIM-3 antibody
0
‌
US Patent 11034765 Anti-PD-1 antibodies and compositions
0
‌
US Patent 11390674 Anti-TIM-3 antibodies and compositions
0
‌
US Patent 11359018 Anti-PD-1 antibodies and compositions
0
‌
US Patent 11390676 Anti-LAG-3 antibodies and compositions
0
‌
US Patent 8354509 Antibodies to human programmed death receptor PD-1
0
‌
US Patent 8927697 PD-1 specific antibodies and uses thereof
0
Patent Inventor Names
Camilla Fröhlich
0
Mikkel Wandahl Pedersen
0
Monika Gad
0
Ivan David Horak
0
Michael Kragh
0
Johan Lantto
0
Trine Lindsted
0
Michael Monrad Grandal
0
Eva Maria Carlsen Melander
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11939380
0
Patent Primary Examiner
‌
Nelson B Moseley, II
0
CPC Code
‌
A61K 2039/505
0
‌
A61K 39/3955
0
‌
Y02A 50/30
0
‌
A61K 2039/507
0
‌
A61K 45/06
0
‌
A61P 35/02
0
‌
A61P 35/00
0
‌
C07K 16/2803
0
‌
C07K 2317/76
0
‌
C07K 2317/92
0
•••

Find more entities like US Patent 11939380 Combination therapies targeting PD-1, TIM-3, and LAG-3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.